| Role |
Name |
Disclosure |
Details |
| Author | Harvey Lui, MD, FRCPC, Professor and Head, Department of Dermatology and Skin Science, Vancouver General Hospital, University of British Columbia; Medical Director, The Skin Centre, Lions Laser Skin Centre and Psoriasis and Phototherapy Clinic, Vancouver General Hospital | Astellas Amgen/Wyeth LEO Pharma LEO Pharma Serono Galderma | Details | | Coauthor | Youwen Zhou, MD, PhD, FRCP(C), Associate Professor, Department of Dermatology and Skin Science, University of British Columbia; Director, Hyperhidrosis Specialty Clinic, Co-Director, Psoriasis and Phototherapy Centre, Consulting Physician, Department of Dermatology, Vancouver General Hospital, Co-Director, Vitiligo and Pigmentation Clinic, Oncologist Consultant, Skin Tumor Program, BC Cancer Agency | Nothing to disclose | Details | | Medical Editor | Sungnack Lee, MD, Vice President of Medical Affairs, Professor, Department of Dermatology, Ajou University School of Medicine, Korea | Nothing to disclose | Details | | Pharmacy Editor | Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center | Nothing to disclose | Details | | Managing Editor | Christen M Mowad, MD, Associate Professor, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details | | CME Editor | Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania | AMGEN AMGEN Genentech Centocor Centocor Covance Shire | Details | | Chief Editor | William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System | elsevier american college of physicians | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Sungnack Lee, Medical Editor |
The contributor discloses no conflict of interest. |
|